Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Nutrition With Insulin in Colorectal Cancer Surgery
NCT02032953Phase 4Withdrawn
- Sponsor
- McGill University Health Centre
- Start
- Dec 2013
- Primary completion
- Apr 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of human insulin, Travesol in colorectal cancer (CRC), sponsored by McGill University Health Centre. Planned start Dec 2013; status: withdrawn.
02
Drugs
human insulinTravesol
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02032953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02032953.